Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Services
Right arrow Email this article to a colleague
Right arrow Alert me to new issues of the journal
Right arrowRights & Permissions

Meetings Abstract

A phase II study of RAD001 (R) (everolimus) monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC) failing prior platinum-based chemotherapy (C) or prior C and EGFR inhibitors (EGFR-I)
J Clin Oncol Vol 25, No 18S (June 20 Supplement), 2007: 7589 V. Papadimitrakopoulou et al.



This Article
Right arrow Full Text
Services
Right arrow Email this article to a colleague
Right arrow Alert me to new issues of the journal
Right arrowRights & Permissions
About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online